Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Herbal Supplements market: $34.4 Bn against $6.6 Bn in 2023, about 5.2 times as large.
China grows faster: 9.1% a year, against 5.6%. The gap still grows from $27.8 Bn to $43.6 Bn by 2033.
Clinical research: 32 active trials in the US, 71 in China.
| Measure | ||
|---|---|---|
| Market size, 2023 | $34.4 Bn | $6.6 Bn |
| Market size, 2033 projected | $59.4 Bn | $15.7 Bn |
| Growth a year (CAGR) | 5.6% | 9.1% |
| Money added, 2023–2033 | $24.9 Bn | $9.2 Bn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $101 | $4.69 |
| Active clinical trials | 32 | 71 |
| Full report | US report | China report |
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Herbal Supplements market: $34.4 Bn against $6.6 Bn in 2023, about 5.2 times as large.
China grows faster: 9.1% a year, against 5.6%. The gap still grows from $27.8 Bn to $43.6 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.